LifeScience BioSimilar
GCCL Launches R&D Division to Bolster Biosimilar and Clinical Trial Analysis Services
Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockb...
July 17, 2024 | News
Biocon Biologics Teams Up with Sandoz Australia for Biosimilar Trastuzumab and Bevacizumab
Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilita...
February 09, 2024 | News
Mabxience and Abbott Forge Strategic Deal to Expand Biosimilars Access in Emerging Markets
Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia and Middle East and Africa mAbxience Holdi...
September 21, 2023 | News
Celltrion Celebrates a Decade of Biosimilar Innovation in Europe
Marking 10 years since the European Medicines Agency (EMA) approved the world’s first monoclonal antibody biosimilar infliximab, for all indication...
September 11, 2023 | News
Mabwell's Biosimilar Denosumab solution approved by NMPA for osteoporosis treatment
Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (...
April 04, 2023 | News
Altos Biologics Enrolls Patients in Global Phase 3 Trial for Eylea® Biosimilar in Neovascular Age-related Macular Degeneration.
Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out disc...
February 23, 2023 | News
Amjevita™ (Adalimumab-atto), First Biosimilar to Humira®, Now Available in the United States
Amgen (NASDAQ:AMGN) announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...
February 01, 2023 | News
BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project
BGI was formed to be a part of the HGP, contributing to the sequencing of genes and working alongside scientists from six countries. Twenty-two years ago t...
June 28, 2022 | News
GenScript establishes Korean legal entity and accelerates sales activities
GenScript Biotech Korea Ltd. has built a nest at IKP (Invest Korea Plaza) in Heolleung-ro, Seocho-gu, Seoul. The main purpose of the establishment of ...
October 05, 2021 | News
Intas, First Indian company to launch a biosimilar product in the EU
Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreeme...
July 22, 2021 | News
Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan
Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...
June 23, 2021 | News
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited
Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...
June 10, 2021 | News
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
